Dr Tian Zhu is passionate about finding new medications for some of the most debilitating medical conditions. Her biotech startup GenEditBio is at the forefront of gene-editing-based therapies that aim to address the urgent medical needs of patients with incurable genetic disorders, specialising in precision medicine based on the Crispr gene-editing technology. It has more than 100 pending patent applications, paving the way for the future of medicine.

Impacted Industries